Biosimilar formulary placement in Medicare Part D prescription drug plans: A case study of infliximab

Medicine & Life Sciences

• Medicare Part D 92%
• Biosimilar Pharmaceuticals 82%
• Formularies 79%
• Prescription Drugs 69%
• Infliximab 69%
• Medicare Part C 23%
• Cost Sharing 22%
• Medicare 20%
• Prior Authorization 15%
• Cost Savings 11%
• Biological Products 9%
• Pharmaceutical Preparations 4%
• Motivation 3%
• Therapeutics 1%

Social Sciences

• medication 50%
• drug 40%
• cost sharing 20%
• authorization 10%
• savings 9%
• drug list 8%
• market 8%
• costs 5%
• incentive 3%
• coverage 3%
• time 1%

Chemical Compounds

• Prescription Drug 100%
• Drug 10%
• Time 3%